The table below shows Praxis Precision Medicines, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Revenue
-
$0.00
$0.00
$0.00
-
$302.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$77.99M
$65.80M
$63.01M
$60.81M
-
$41.88M
SG&A
PRAX annual revenue (10-K history)
Praxis Precision Medicines, Inc. reported annual revenue of $0.00 for fiscal year 2025. That is down 100.0% from $8.55M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.